ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), announces that it began its Canadian brick and mortar rollout in August 2022, through a partnership with Canadian owned retail chain London Drugs, headquartered in Richmond, British Columbia. Else's Plant-Based Nutrition for Toddlers and Kids Nutritional Shakes are on shelf and available for purchase in London Drugs stores and will be available in 73 stores across Western Canada. With pharmacy retail stores in 36 major markets throughout British Columbia, Alberta, Saskatchewan, and Manitoba, the partnership gives Else Nutrition ideal access to parents purchasing for their children.
London Drugs will also soon be adding Else Nutrition products to their online store at LondonDrugs.com which will deepen the distribution relationship and expose Else Nutrition to additional London Drugs customers.
“Launching our Canadian retail rollout with an outstanding partner such as London Drugs is an exciting, and strategically sound initiative for Else,” said Hamutal Yitzhak, CEO and Co-Founder of Else Nutrition. “Entering the Canadian marketplace in Western Canada via London Drugs, introduces our brand to a vibrant and healthy-minded consumer-base in the West, while acting as a springboard into greater Canada,” she continued.
“London Drugs’ large-format shelves and loyal family-driven customers across British Columbia, Alberta, Saskatchewan, and Manitoba will help Else Nutrition acquaint itself with parents who are actively seeking better nutritional solutions for their little ones, whilst in a familiar and trusted retail pharmacy environment,” added Hamutal Yitzhak.
For more information, visit: www.elsenutrition.com or @elsenutrition on Facebook and Instagram.
About London Drugs
Founded in Vancouver, BC, in 1945, London Drugs today has stores in more than 35 major markets throughout British Columbia, Alberta, Saskatchewan, and Manitoba. While the pharmacy is the heart of their business, they also offer a full-service computer department, cosmetics ranging from lip gloss to high-end face creams, furniture, cameras, high-quality photo finishing, and hi-tech electronics. More people also buy their small appliances in London Drugs than in any other place in Western Canada. All told, London Drugs serves over 45 million customers each year and is still growing. They are a staple in Canadian retail and instrumental to Western Canada’s diverse and vibrant communities.
London Drugs is 100% Canadian-owned and is focused on local customers' satisfaction. Across Alberta, Saskatchewan, Manitoba, and British Columbia, London Drugs' over 79 stores employ more than 8000 staff dedicated to providing their customers with a superior shopping experience. London Drugs is owned by HY Louie Co. and Parent company Georgia Main Food Group.
12251 Horseshoe Way
Richmond, British Columbia
About Else Nutrition Holdings Inc.
Else Nutrition Holdings Inc. is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the "2017 Best Health and Diet Solutions" award at Milan's Global Food Innovation Summit. The holding company, Else Nutrition Holdings Inc., is a publicly-traded company, listed on TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets Q.X. board under the trading symbol BABYF and the Frankfurt Exchange under the symbol 0YL. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents and gained national retailer support from Sprouts Farmers Market, and achieved rapid sales growth. Else became the #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler Formula Category. It recently won the 'Best Dairy Alternative' Award 2021 at World Plant-Based Expo and was a Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle category.
Investor Relations Contact:
RBMG – RB Milestone Group LLC
Trevor Brucato, Managing Director
Lytham Partners, LLC
Mr. Ben Shamsian
New York | Phoenix
TSX Venture Exchange
Neither the TSX Venture Exchange nor its regulation services provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Caution Regarding Forward-Looking Statements
This press release contains statements that may constitute "forward-looking statements" within the meaning of applicable securities legislation. Forward-looking statements are typically identified by words such as "will" or similar expressions. Forward-looking statements in this press release include statements with respect to the anticipated dates for filing the company's financial disclosure documents. Such forward-looking statements reflect current estimates, beliefs, and assumptions, which are based on management's perception of current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. No assurance can be given that the foregoing will prove to be correct. Forward-looking statements made in this press release assume, among others, the expectation that there will be no interruptions or supply chain failures as a result of COVID 19 and that the manufacturing, broker, and supply logistic agreement with the company does not terminate. Actual results may differ from the estimates, beliefs, and assumptions expressed or implied in the forward-looking statements. Readers are cautioned not to place undue reliance on any forward-looking statements, which reflect management's expectations only as of the date of this press release. The company disclaims any obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law.